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A better understanding of the molecules implicated in the growth and survival of glioblastoma (GBM) cells and
their response to temozolomide (TMZ), the standard-of-care chemotherapeutic agent, is necessary for the
development of new therapies that would improve the outcome of current GBM treatments. In this study, we
characterize the role of pericentriolar material 1 (PCM1), a component of centriolar satellites surrounding
centrosomes, in GBM cell proliferation and sensitivity to genotoxic agents such as TMZ. We show that PCM1 is
expressed around centrioles and ciliary basal bodies in patient GBM biopsies and derived cell lines and that its
localization is dynamic throughout the cell cycle. To test whether PCM1 mediates GBM cell proliferation and/or
response to TMZ, we used CRISPR/Cas9 genome editing to generate primary GBM cell lines depleted of PCM1.
These PCM1-depleted cells displayed reduced AZI1 satellite protein localization and significantly decreased
proliferation, which was attributable to increased apoptotic cell death. Furthermore, PCM1-depleted lines were
more sensitive to TMZ toxicity than control lines. The increase in TMZ sensitivity may be partly due to the reduced
ability of PCM1-depleted cells to form primary cilia, as depletion of KIF3A also ablated GBM cells' ciliogenesis and
increased their sensitivity to TMZ while preserving PCM1 localization. In addition, the co-depletion of KIF3A and
PCM1 did not have any additive effect on TMZ sensitivity. Together, our data suggest that PCM1 plays multiple
roles in GBM pathogenesis and that associated pathways could be targeted to augment current or future anti-
GBM therapies.
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Glioblastoma (GBM) is the most common malignant brain tumor in
adults with an extremely poor prognosis, mostly due to primary and
acquired resistance to standard-of-care treatments, i.e., chemotherapy
and irradiation [1,2]. A more complete understanding of the cellular
and molecular mechanisms that ensure the proliferation and survival
of GBM cells despite aggressive therapies is crucial for the
development of new treatment modalities that would further inhibit
tumor progression.
GBM cells contain a matrix of pericentriolar material that
comprises satellite proteins and surrounds centrioles, which form
Translational Oncology Vol. 9, No. 5, 2016 Effects of PCM1 Depletion in GBM Hoang-Minh et al. 393basal bodies during ciliogenesis. Pericentriolar proteins (PCPs) play
crucial roles in cell division and survival, particularly in microtubule
and actin organization, centrosome stability, centriolar duplication
prior to mitosis [3–11], as well as ciliogenesis [12–20], in several cell
types. Several PCPs are also closely associated with DNA repair
proteins in centrosomes [21–24] and undergo significant subcellular
reorganization in response to various cellular stresses (e.g., heat shock
and UV radiation [25,26]), in some cases mediating DNA
damage-induced centrosome amplification and tumorigenesis
[27,28]. However, the degree to which various PCPs affect GBM
pathogenesis and sensitivity to therapy is poorly understood.
Pericentriolar material 1 (PCM1) is an essential PCP that is
required for the cellular processes mentioned above in some normal
and malignant cell types [25,29–32]. PCM1 has also been shown to
bind to several centrosomal proteins, including pericentrin [30,33]
and Cep131/AZI1 [10], ensuring their correct localization [18].
However, the extent of PCM1’s expression in GBM cells or its
function in GBM growth and/or stress response has never been
studied. We recently reported that PCM1 localizes around the
majority of centrioles and basal bodies situated at the base of primary
cilia of patient-derived GBM cells in vitro [34]. In the present study,
we further examine whether PCM1 is expressed in GBM biopsies and
patient-derived GBM cell lines and study its localization during GBM
cell division. In addition, we investigate the in vitro consequences of
PCM1 depletion on the localization of other PCPs, GBM cell
ciliogenesis, cell proliferation, and sensitivity to standard-of-care
chemotherapeutic agent temozolomide (TMZ).
Materials and Methods
Generation and Maintenance of PCM1 and KIF3A-Depleted
Cell Lines
The primary cell lines used in this study, Line 0 (L0; 43-year-old
man) and mCherry-expressing SN186 (S3; 75-year-old man) [34],
were isolated from human GBM tumors [35–39] and cultured as
previously described [34]. Briefly, cells were grown as floating spheres
and maintained in DMEM/F12 medium supplemented with 2%
B27, 1% penicillin-streptomycin, 20 ng/ml human EGF, and
10 ng/ml human bFGF. When the spheres reached approximately
150 μm in diameter, they were enzymatically dissociated by digestion
with Accumax (Innovative Cell Technologies, Inc.) for 10 minutes at
37°C. Cells were washed, counted using Trypan blue to exclude
dead cells, and replated in fresh medium supplemented with hEGF and
bFGF.
To generate PCM1-depleted patient-derived GBM cell lines, we
screened and identified CRISPR/Cas9-encoding plasmids containing
a GFP reporter gene that could target human PCM1 [Sigma-Aldrich;
CRISPR/Cas-GFP vector (pU6-gRNA-CMV-Cas9:2a:GFP); primer
pair ID: HS0000328679; PCM1 gRNA target sequence:
GACTCCGGAGAAATATCATTGG]. We used the same approach
to generate GBM cell lines depleted of KIF3A [Sigma-Aldrich;
CRISPR/Cas-GFP vector (pU6-gRNA-CMV-Cas9:2a:GFP); primer
pair ID: HS0000342157; KIF3A gRNA target sequence: GGTCA
TATTGCAAAAGCGGAGG]. Clones depleted of both PCM1 and
KIF3A were generated by co-transfection. For transfection experi-
ments, GBM cells were grown on 10-cm2 plates and transfected
(Lipofectamine 2000; Life Technologies) at 60% to 70% confluence
with 0.5 μg/ml of the CRISPR/Cas9-encoding plasmid DNA.
Twenty-four to 48 hours after transfection, GFP-positive cells weresorted as individual clones into 96-well plates containing 250 μl of
DMEM/F12 medium supplemented with hEGF and bFGF using a
BD FACS Aria II Cell Sorter (BD Biosciences, San Jose, CA),
excluding cell debris from the analysis by forward- and side-scatter
gating. Stable cell lines from each GFP-positive clone were then
expanded and screened for presence or absence of PCM1 or KIF3A
proteins by immunostaining and Western blotting (WB).
GFP-positive clones with immunopositive PCM1 clusters and
detectable PCM1 levels by WB were termed PCM1-positive control
clones (L0 clone D5 and S3 clone F11), whereas those with no
immunopositive PCM1 clusters and undetectable PCM1 levels by
WB were designated PCM1-depleted clones (L0 clone F9 and S3
clone B9). Further, DNA sequencing around the CRISPR/Cas9
target site in exon 4 of PCM1 of S3 clones revealed significant base
pair deletions and point mutations in the PCM1-depleted clone B9
compared with controls (data not shown).
For immunostaining, once cells formed spheres greater than
100 μm in diameter in each well, the spheres were mechanically
dissociated, replated, and expanded into 24-well plates on glass
coverslips in DMEM/F12 medium supplemented with 5% FBS.
After 2 to 3 days, cells were fixed with 4% paraformaldehyde in
0.1 M phosphate buffer (4% PFA) for immunohistochemical analysis
as described below. For WB, cells were expanded in T25 flasks for 1
week prior to analysis and harvested as described below.
Western Blot
S3 and L0 cells were harvested and lysed in 1× RIPA buffer (Cell
Signaling) containing 1× protease inhibitor cocktail (Sigma),
phosphatase inhibitor cocktails 1 and 2 (Sigma), and 1× phenyl-
methanesulfonyl fluoride (Sigma). For WB of PCM1, 20 μg of total
protein lysate per lane was separated on a 4% to 12% Bis-Tris gel
(NuPage). Proteins were blotted onto PVDF membranes using iBlot
(program 3 for 8 minutes; Invitrogen). Blots were blocked in 5%
nonfat dry milk (NFDM) in 1× TBS with 0.1% Tween (TBST) for
1 hour and then incubated in primary anti-PCM1, anti-KIF3A, or
anti–beta-actin antibodies in 2.5% NFDM in 1× TBST for 24 hours
at 4°C. Blots were then rinsed and probed in the appropriate
HRP-conjugated secondary antibody (1:10,000; BioRad; cat #
170-6515; lot # 310008703) for 1 hour at room temperature in
2.5% NFDM in 1× TBST. Finally, blots were rinsed in 1× TBS and
developed using an ECL-plus chemiluminescence kit (Amersham),
and images were captured using an AlphaInnotech Fluorchem Q
Imaging System (Protein Simple).
Antibodies, Immunostaining, and Image Acquisition
The following primary antibodies were used for immunocyto-
chemistry (ICC), immunohistochemistry (IHC), and WB: mouse
anti–acetylated alpha-tubulin (aa-tub) [1:3000 (ICC); Sigma (cat #
T6793; lot # 088K4829)], mouse anti–gamma-tubulin (gTub)
[1:2000 (ICC); Sigma (cat # T6557; lot # 072M4808)], rabbit
anti-PCM1 [1:1000 (ICC/IHC/WB); Bethyl Laboratories (cat #
A301-150A; lot # A301-150A-1)], rabbit anti-AZI1 [1:1000 (ICC);
Abcam (cat # ab84864; lot # GR13395-12)], rabbit anti-Cep290
[1:1000; Abcam (cat # ab84870; lot # GR32927-13)], rabbit
anti-Ki67 [1:200 (ICC); Vector (cat # VP-RM04; lot # V0523)],
rabbit anti-KIF3A [1:1000 (WB); Abcam (cat # ab11259)], rabbit
anti-PHH3 [1:1000 (ICC); Millipore (cat # 06-570; lot # 2066052)],
and rat anti-BrdU [1:1000 (ICC); Accurate (cat # OBT0030; lot #
H7227)]. For BrdU staining, cells were rinsed with 0.9% NaCl,
Figure 1. PCM1 is widely expressed in cells from GBM patient tumor-derived cell lines and biopsies. (A) Example of cells from the S3 cell
line immunostained for PCM1 (green). Nuclei are counterstained with DAPI (blue). (B) Magnification of the inset in A. Cells were also
immunostained for gTub (red in merged). Note the PCM1-positive cluster of granules surrounding gTub-positive puncta (arrowheads). (C)
Immunostaining for PCM1 (green) in a tumor resulting from the xenotransplantation of S3 cells (stained mouse brain section from [34]).
(D) Example of a GBM biopsy immunostained for PCM1 (green) with nuclei counterstained with DAPI (blue). The boxed inset shows
clustering of PCM1 around gTub + puncta. (E) Examples of archived biopsies from five individuals of various ages with high-grade glioma
immunostained for PCM1 (brown). PCM1-positive puncta (arrows) are observed across samples. Images were derived from the Human
Protein Atlas (www.proteinatlas.org). Scale bars in A = 5 μm; C, D = 5 μm.
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to immunostaining. Secondary antibodies were species-specific and
conjugated with fluorescent tags [1:400 (ICC/IHC); Jackson
Immunoresearch]. Stained sections and cells were coverslipped with
Prolong Gold antifade media containing DAPI (Invitrogen). For
some of our analyses, sections of a tumor formed from an S3 cell
intracranial xenograft in a male NOD/SCID mouse were obtained
from our previous study [34]. Immunostained cells and sections were
examined and imaged using an Olympus IX81-DSU confocal
microscope fitted with a 60× water objective, and all images were
captured as z-stacks (0.5-μm steps). Nonconfocal images and
time-lapse videos were acquired using a Zeiss Axio Observer D1
inverted microscope equipped with an AxioCam MRm camera and
analyzed using ZEN software.
Cell Growth, Viability, and Survival Assays
For cell proliferation assay, cells (5 × 104) were seeded in 1 ml of
growth media per well in 24-well plates for each experimental group.
Cells were enzymatically dissociated and counted after 5 days using a
hemocytometer. Cells were stained with 0.04% Trypan blue at the
time of dissociation to identify dead (Trypan blue–positive) cells.These cells were counted, and the percentage of dead cells was
calculated for each group at the time of each passage.
To assess the effects of in vitro TMZ treatment on cell viability,
10,000 cells per experimental group were plated per well into 96-well
cell culture plates and treated daily for 5 days with TMZ (50 or 100
μM, Tocris, Ellisville, MO) in 10% DMSO. Vehicle-control wells
received equivalent volumes of DMSO. Cell viability was assessed
with the 3-(4, 5-dimethylthiazole-yl)-2, 5-diphenyl tetrazolium
bromide (MTT) assay as previously described [34]. The number of
viable cells was determined through optical density measurements (by
measuring absorbance at 570 nm).
To determine the percentage of cleaved caspase 3–positive cells,
cells (5 × 105) were pelleted, resuspended in 1 ml of 4% PFA, and
incubated for 15 minutes at room temperature. The suspension was
then centrifuged and the pellet washed twice with PBS. Labeling was
performed by incubating the cells in rabbit anti–cleaved caspase-3
primary antibody (Asp175) [1:1000; Cell Signaling (cat # 9661S; lot
# 42)] overnight at 4°C, followed by incubation in an anti-rabbit,
FITC-tagged secondary antibody [1:400 (ICC/IHC); Jackson
Immunoresearch] for 1 hour at room temperature. Cells were then
washed in PBS, DAPI-stained, and analyzed by flow cytometry.
Figure 2. PCM1 granules in L0 GBM cells display a dynamic distribution throughout the cell cycle. Co-immunostaining of L0 cells for
PCM1 (green) and aa-tub (red) with nuclei counterstained with DAPI (blue). Cells in various stages of the cell cycle (prophase, metaphase,
anaphase, telophase, and interphase) show a cell cycle–dependent assembly and disassembly of PCM1 granules and aggregates. Scale
bar =5 μm.
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tagged secondary antibodies were run in parallel.
Data Analysis
Statistical analyses were performed using GraphPad Prizm 5.0
(GraphPad Software, La Jolla, CA). In all analyses, P values less than .05
were considered significant. Comparisons between groups were
performed using either a Student's t test or one-way analysis of variance
(ANOVA) followed by Tukey's post hoc analysis, as indicated.
Results
Expression of PCM1 in Patient-Derived GBM Cell Lines,
Associated Tumors, and Patient Biopsies
In other cancer cell types (e.g., HeLa, U2OS [3,7,25]), PCM1
expression appears in the form of granules or puncta that surround
centrioles, structures typically containing gTub. To identify PCM1 in
two patient-derived GBM cell lines, L0 and S3, we co-immunostained
cells with antibodies raised against PCM1 and gTub. We found smallPCM1-positive granules typically concentrated around gTub-positive
centrioles in the majority of cells from the GBM cell lines we examined,
e.g., S3 (Figure 1, A and B). A similar staining pattern was observed
within the tumors that formed following the intracranial xenotrans-
plantation of these S3 cells into mice (Figure 1C) [34]. Furthermore,
examination of freshly stained or archived GBM biopsies from patients
of various ages [40,41] also showed clusters of PCM1 granules in every
sample (Figure 1, D and E). Thus, PCM1 expression is preserved and
ubiquitous in patient-derived GBM cell lines and specimens.
Previous studies have reported that PCM1 subcellular localiza-
tion is dynamic throughout the cell cycle, with the distribution
pattern of PCM1 granules changing as cells proceed from interphase
to mitotic telophase [7,29–31,42]. Similarly, in both patient-derived
GBM L0 (Figure 2) and S3 (Supplemental Figure S1) cell lines, we
found that PCM1 granules were concentrated in clusters during
interphase and dispersed around the nucleus during all stages of
mitosis. Time-lapse imaging of live GBM cells transfected with a
plasmid encoding EGFP-tagged human PCM1 (gift from S. Shi [43])
further illustrates the dynamic nature of these PCM1 granules that are
Figure 3. PCM1-depleted GBM cell lines generated using CRISPR/Cas9. A CRISPR/Cas9 plasmid co-expressing a GFP reporter for Cas9
and gRNA directed against human PCM1 was used to transfect L0 and S3 GBM cells and generate cell clones depleted of PCM1.
GFP-positive clones were FAC-sorted and expanded for screening by WB and immunostaining. (A) WB of L0 lysates shows that,
compared with clone D5, clone F9–derived cells displayed an absence of a band for PCM1. β-Actin was used as a loading control. (B)
Immunostaining of L0 clones shows the presence of PCM1-positive clusters (green) in clone D5 but not clone F9–derived cells (right
panels). (C, D) Similarly, S3 cells generated from clone B9 lacked detectable PCM1 by WB (C) and ICC (D) compared with clone F11.
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described in Xenopus A6 cells [14]. Together, these data show that
PCM1’s localization is dynamic and undergoes subcellular changes
during GBM cell division, suggesting that PCM1 may play a role in
GBM cell proliferation.
Depletion of PCM1 Using CRISPR/Cas9 Genome Editing
in GBM Cell Lines and AZI1 Centriolar Satellite Protein
Organization
To investigate the functions of PCM1 in GBM cell proliferation,
we used the CRISPR/Cas9 genome editing technology to deplete
PCM1 expression from our L0 and S3 GBM cell lines. We
transfected GBM cells with a plasmid encoding RNA-guided Cas9
endonuclease with a GFP reporter and a trans-activating guide RNA
designed against human PCM1 under the control of a U6 promoter.
Single GFP-positive clones were isolated using FACS and expanded.To identify PCM1-depleted clones, we screened cell lines derived
from those GFP-positive clones using WB and ICC for PCM1. For
both L0 and S3 cell lines, we identified clones that were characterized
by undetectable PCM1 (e.g., L0 clone F9, S3 clone B9; Figure 3, A
and C) as well as clones that expressed PCM1 (“PCM1-positive
control” L0 clone D5, S3 clone F11; Figure 3, A and C) using WB.
Immunostaining using an antibody against PCM1 revealed
PCM1-positive clusters in the majority of cells derived from
PCM1-positive control clones but no PCM1-positive clusters in
cells originating from PCM1-depleted clones for L0 or S3 cell lines
(Figure 3, B and D).
We next examined the localization of known PCM1-associated
proteins. We found that L0 and S3 PCM1-depleted lines displayed
loss of AZI1 from pericentriolar satellites, whereas its localization at
the centriolar core remained unaffected (Figure 4, A and B),
observations which are consistent with those in other studies showing
Figure 4. AZI1 recruitment to GBM centriolar satellites is
dependent on PCM1. Immunostaining for AZI1 (green; arrows)
with nuclei counterstained with DAPI (blue) for (A) L0 cells derived
from PCM1-positive control clone D5 and PCM1-depleted clone F9
and (B) S3 cells derived from PCM1-positive control clone F11 and
PCM1-depleted clone B9. In both lines, note the reduced
localization of AZI1 granules at pericentriolar satellites in PCM1-
depleted compared with wild-type clones. (C) S3 cells derived from
PCM1-depleted clone B9 were transfected with a plasmid
encoding human wild-type EGFP-tagged PCM1 and immuno-
stained for AZI1. Arrows show a transfected cell expressing
EGFP-tagged PCM1 (green) co-localizing with AZI1 (red). The
arrowhead points to AZI1 expression in an adjacent nontransfected
cell. Scale bars in A, B, C = 5 μm.
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localization of centrosomal proteins [18]. Surprisingly, not all
centrosomal proteins' localization was altered following PCM1
depletion. We observed similar expression patterns for Cep290, a
centrosomal protein that interacts with AZI1 and PCM1 [10], in
control and PCM1-depleted cells (Supplemental Figure S2).
Importantly, transfecting PCM1-depleted GBM cells with a plasmid
encoding wild-type, EGFP-tagged human PCM1 restored the AZ1
centriolar satellite localization pattern compared with untransfectedcells (Figure 4C). Together, these data support a critical role for
PCM1 in organizing and recruiting certain proteins to the centriolar
satellites of GBM cells.
Decreased Cell Proliferation Through Increased Apoptotic Cell
Death Following PCM1 Depletion
Considering the reported influence of PCM1 on microtubule
organization in other cell types [30], its dynamic localization around
the centrosome during cell cycle progression (Figure 2, Supplemental
Figure S1), and the centriolar satellite changes observed following its
depletion in GBM cells (Figure 4) [18], we next examined whether
the depletion of PCM1 from L0 and S3 GBM cells affected these
cells' baseline proliferation. We observed a significant decrease in cell
proliferation for PCM1-depleted L0 (Figure 5A) and S3 (Figure 5D)
cell lines compared with cells derived from PCM1-positive control
clones. To assess whether this decrease was due to aberrant cell
division, we examined the distribution of these cells among the
various phases of the cell cycle using immunostaining for markers of
actively proliferating cells (Ki67+), as well as cells in the G2/M
(phospho-histone H3 + (PHH3+)) and S (BrdU+) phases (Supple-
mental Figure S3A). We found no significant differences in cell cycle
distribution between cell populations derived from PCM1-positive
control clones and those derived from PCM1-depleted clones for
both L0 (Figure 5B) and S3 (Figure 5E) cell lines.
We next assessed apoptotic cell death by flow cytometry using
active caspase 3 immunostaining and observed an increased
percentage of apoptotic cells in PCM1-depleted clones compared
with PCM1-positive control clones for both L0 (Figure 5C;
Supplemental Figure S3B) and S3 (Figure 5F) cell lines. The
percentage of dead cells assessed by Trypan blue staining was also
increased in PCM1-depleted clones compared with control
clones (Figure 5, C and F). Notably, the percentages of active caspase
3–positive and Trypan blue–positive dead cells were higher in L0
than in S3 PCM1-depleted cell line, despite a smaller decrease in cell
proliferation for L0 than for S3 cell line after PCM1 depletion. This
discordance could be due to a loss of dead/fragmented S3 cells during
the dissociation and staining process. Together, these results suggest
that the decrease in cell proliferation following PCM1 depletion is
due to an increase in apoptotic cell death rather than a change in cell
cycle phase distribution, a result that has been observed in multiple
other cancer cell lines following siRNA-mediated knockdown of
PCM1 [7,30].
Sensitivity of GBM Cells to TMZ After PCM1 Depletion
Because the loss of PCM1 induced GBM cell apoptosis, we
hypothesized that PCM1 depletion prevents GBM cells from
engaging in PCM1-associated survival pathways, thus rendering
those cells more sensitive to TMZ toxicity. To test this hypothesis, we
examined whether TMZ treatment differentially affected the viability
of control and PCM1-depleted cells. Consistent with our cell
proliferation data shown above, our MTT assay results show that
baseline (vehicle-treated) cell viability is significantly decreased in
PCM1-depleted S3 (by ~40%; Figure 6A) and L0 (~15%; Figure 6B)
cells compared with their respective controls. Notably, we found that
daily treatment with 50 μM TMZ for 5 days significantly decreased
the viability of S3 control cells by ~10% and the viability of S3
PCM1-depleted cells by ~50%. The same 50-μM TMZ treatment
course also decreased the viability of L0 control cells by ~44% as well
as the viability of L0 PCM1-depleted cells by ~57% (Figure 6C).
Figure 5. PCM1 depletion results in reduced GBM cell proliferation due to increased apoptotic cell death. (A, D) Average cell numbers per
well 5 days after plating for L0 (A) and S3 (D) cell lines derived from PCM1-positive control clones (open-filled bars) or PCM1-depleted
clones (black-filled bars). (B, E) Percentages of cells from control or PCM1-depleted clones that were Ki67+, PHH3+, or BrdU+ for L0 (B)
and S3 (E) cell lines 5 days after plating. (C, F) Percentages of cleaved caspase 3–positive immunolabeled cells detected by FACS and
percentages of Trypan blue–labeled cells 5 days after passaging for L0 (C) and S3 (F) cell lines. *P b .05, **P b .01, ***P b .001, Student's
t test.
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PCM1-depleted cells' viability was reduced by 67% for S3 cells and
by 57% for L0 cells compared with 40% and 44%, respectively, for
the PCM1-positive control cells. Thus, these data suggest that
PCM1-depleted cells are more sensitive to TMZ exposure than
control cells. Together, the induced apoptosis and increased
sensitivity to TMZ resulting from PCM1 depletion have significant
additive effects in inhibiting GBM cell proliferation.
We next investigated possible mechanisms that might underlie the
increased sensitivity of GBM cells to TMZ following PCM1
depletion. In multiple cell types, PCM1 has been reported to
promote the biogenesis of cilia [18,25,32,44–49], cellular “signaling
antennae” structures typically formed during the G0/G1 phases of the
cell cycle. Notably, in U2OS osteosarcoma cells, various cellular
stresses including UV radiation, transcriptional inhibitors, and heat
shock have been reported to stimulate ciliogenesis via PCM1 [25].We visualized the primary cilia of S3 and L0 cells using an antibody
against aa-tub, a molecule that is enriched in the ciliary axonemes of
GBM cells [34,35] (Figure 7A), and found a significant decrease in
the percentage of ciliated cells in L0 and S3 PCM1-depleted cell lines
compared with control cell lines (Figure 7B). We then examined
whether the increased sensitivity of PCM1-depleted cells to TMZ
might be associated to the reduced ability of these cells to form cilia.
We compared the TMZ sensitivity of L0 control and PCM1-depleted
clones to that of another line of L0 GBM cells in which we used
CRISPR/Cas9 genome editing technique to deplete KIF3A, a kinesin
motor protein essential for GBM ciliogenesis [34] (Figure 7C). L0
GBM cells depleted of KIF3A were rarely ciliated (Figure 7D), while
retaining a normal PCM1 expression pattern, compared with L0
KIF3A-positive control cells (Figure 7E). We found that five daily
100-μM TMZ treatments significantly reduced the viability of both
PCM1 and KIF3A-depleted L0 cells compared with vehicle-control
Figure 6. PCM1-depleted cells are more sensitive to TMZ-associated toxicity than control cells. MTT assays were used to measure cell
viabilities after five daily exposures to TMZ (50 or 100 μM) or vehicle (DMSO) for S3 (A) and L0 (B) cell lines. Bar graphs show the
percentages of viable cells derived from control clones (S3-F11 and L0-D5) or PCM1-depleted clones (S3-B9 and L0-F9) after exposure to
vehicle or TMZ. Data were normalized to control-vehicle groups for each cell line. (C) Table shows the percent decrease in cell viability that
was calculated relative to the vehicle groups for control and PCM1-depleted cell lines. ***P b .001, ANOVA with Tukey's post hoc.
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PCM1-depleted cells to TMZ (Figure 7G). To determine whether
there were additive effects of KIF3A and PCM1 co-depletion, we
generated L0 cells depleted of both PCM1 and KIF3A using CRISP/
Cas9 (Figure 7F), and although these cells were also significantly
more sensitive to TMZ compared with control cells, this increase in
TMZ sensitivity was not significantly different from that of
KIF3A-depleted cells (Figure 7G). Thus, there were no additive
effects of PCM1 and KIF3A co-depletion on TMZ sensitivity, and
the increased TMZ sensitivity resulting from the double depletion
was largely due to the loss of KIF3A/cilia and not to extraciliary effects
resulting from PCM1 depletion. These results, and the fact that
KIF3A/cilia-depleted cells retained a normal PCM1 expression
pattern, suggest that the loss of cilia in PCM1-depleted cells is
associated to the increased TMZ sensitivity of those cells. These data
also suggest that the loss of genes critical for ciliogenesis may lead to a
heightened sensitivity of certain GBM cells to TMZ.
Discussion
Very little is known about the role of PCM1 in brain tumors. Here,
we characterize the expression of PCM1 in GBM cells and the effects
of depleting PCM1 on GBM centriolar satellite protein expression,
ciliogenesis, cell proliferation, and sensitivity to TMZ. PCM1 is
widely expressed around the centrioles in GBM cell lines and biopsies.
As others have reported in normal and malignant cell types (e.g.,HeLa, osteosarcoma cells, myoblasts) [29,30], we show that PCM1
distribution is dynamic throughout the cell cycle in GBM cells, with
PCM1 granules being particularly concentrated around the centro-
somes during interphase and dispersed around the cytoplasm during
mitosis. PCM1’s role in recruiting other proteins to centriolar
satellites appears to be preserved in GBM cells. Indeed, PCM1 has
been shown to bind and recruit AZ1 to centriolar satellites [10,50].
We found that PCM1-depleted cells displayed a loss of AZI1 from
pericentriolar satellites, whereas AZI1’s localization at the centriolar
core remained unaffected, similarly to previous reports in Hela and
U2OS osteosarcoma cells [10]. The presence of small concentrated
clusters of AZI1 observed following PCM1 depletion suggests that
the localization of AZI1 is not entirely dependent on PCM1 but also
other centrosomal proteins. For instance, Cep290 interacts with
AZI1 and promotes its localization in other cell types [10]. We found
that Cep290’s expression pattern was unaltered following PCM1
depletion; thus, Cep290 could help promote the localization of AZI1
to the centriolar core in PCM1-depleted GBM cells. Interestingly,
Kim et al. [32] showed that hTERT-RPE cells depleted of PCM1
using small interfering RNA displayed disrupted Cep290 localization
at centriolar satellites, suggesting that PCM1’s function may differ
between GBM cells and other cell types. We also observed that
exogenously expressing wild-type PCM1 in PCM1-depleted cells
restored the pattern of AZI1 localization around the centriolar
satellites. This observation is consistent with recent findings in
Figure 7. Loss of cilia in PCM1- and KIF3A-depleted GBM cells is associated with increased TMZ sensitivity. (A) Examples of L0 and S3 cell
cilia (arrows) co-immunostained for aa-tub (red), enriched in the ciliary axoneme, and PCM1 granules (green), enriched in the region
surrounding the basal bodies of cilia. Nuclei were counterstained with DAPI (blue). (B) Percentages of aa-tub–positive cilia on L0 cells,
derived from PCM1-positive control clone D5 or PCM1-depleted clone F9, and S3 cells, derived from PCM1-positive control clone F11 and
PCM1-depleted clone B9. (C) A CRISPR/Cas9 plasmid co-expressing a GFP reporter for Cas9 and gRNA directed against human KIF3A
was used to transfect L0 GBM cells and generate cell clones depleted of KIF3A. GFP-positive clones were FAC-sorted and expanded for
screening by WB and immunostaining. WBs of L0 lysates show that, compared with clone E3, clone B8–derived cells displayed an
absence of a band for KIF3A. GAPDH was used as a loading control. (D) Percentages of aa-tub–positive cilia on L0 cells derived from
KIF3A-positive control clone E3 or KIF3A-depleted clone B8. (E) Examples of L0 KIF3A-positive control and KIF3A-depleted cells generated
using CRISPR/Cas9 and co-immunostained for aa-tubulin (red) and PCM1 granules (green). (F) CRISPR/Cas9 plasmids co-expressing a
GFP reporter for Cas9 and gRNA directed against human KIF3A or human PCM1were used to co-transfect L0 GBM cells and generate cell
clones depleted of both PCM1 and KIF3A. GFP-positive clones were FAC-sorted and expanded for screening byWB and immunostaining.
WBs of L0 lysates show that, compared with clone D1, clone E3–derived cells displayed an absence of bands for both PCM1 and KIF3A.
GAPDH was used as a loading control. (G) Bar graphs show the percentages of L0 viable cells derived from control (wild type),
PCM1-depleted (clone F9), KIF3A-depleted (clone B8), and PCM1/KIF3A-depleted (clone E3) cell lines after five daily exposures to 100 μM
TMZ or DMSO vehicle. *P b .05, ***P b .001, n.s. = nonsignificant; (B) and (D) Student's t test; (G) ANOVA with Tukey's post hoc. Scale
bars in A = 5 μm; E = 10 μm.
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PCM1 is required for AZI1 centriolar satellite localization [18].
Together, our data show that PCM1, a ubiquitous centrosomal
protein in GBM cells, is dynamically localized throughout cell
division and regulates the recruitment of other centriolar satellite
proteins such as AZI1.
Surprisingly, depletion of PCM1 did not lead to changes in GBM
cell cycle phase distribution, despite the dynamic distribution of
PCM1 observed throughout the cell cycle. Rather, we observed a
decrease in net cell proliferation due to induced apoptotic cell death,which is consistent with results obtained following siRNA-mediated
knockdown of PCM1 in other cell types [7]. Interestingly, the
apoptotic cell death caused by reducing PCM1 levels using small
interfering RNA in other cancer cell lines was minimal compared with
that caused by knocking down other centrosomal proteins (e.g.,
ninein, aurora-A, TOG, and TACC3) [7]. These findings suggest
that targeted loss or inhibition of other GBM centrosomal proteins in
addition to PCM1 could result in further cell death. While our data
indicate a role for PCM1 in GBM cell proliferation, the exact
mechanisms require further investigation.
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in both L0 and S3 cells, result which is consistent with the role of
PCM1 in cilia biogenesis that has been found in other cell types
[18,20,25,32,44–49]. Although some studies have reported that
primary cilia are either rarely or poorly formed in many of the widely
used GBM lines [51,52], examination of more recently derived
primary lines and biopsies has revealed the presence of structurally
intact cilia with PCM1 around their basal bodies [34,35]. PCM1,
through its interaction with other centriolar proteins, can promote
various critical ciliogenesis processes such as ciliary vesicle docking to
the mother centriole (e.g., Rab8-positive vesicles), displacement of
cilia inhibitory proteins, and recruitment of other essential ciliogenic
proteins [18,25,32,44–49]. Similarly, loss of AZI1 has also been
found to inhibit ciliogenesis [12,15,16], and the abnormal
localization of AZI1 could have contributed to the decreased ciliation
of GBM cells following PCM1 depletion. Our finding that PCM1 is
required for GBM ciliogenesis may be significant if GBM cilia serve as
venues for promoting tumorigenesis, as has been observed in other
cancer types (e.g., medulloblastoma, basal cell carcinoma, choroid
plexus tumors) [53–55]. Our previous findings show that GBM cells
are capable of forming ciliated progeny and that, in some GBM cell
lines (e.g., L0), primary cilia transduce signals, such as Sonic
hedgehog, that stimulate GBM cell proliferation [34].
For both L0 and S3 GBM cell lines, PCM1-depleted cells showed
enhanced TMZ sensitivity compared with the respective PCM1-positive
control cells. Given the ubiquity of PCM1 across lines and biopsies, it will
be important to verify whether all GBM cell lines display higher TMZ
sensitivity following PCM1 suppression in future studies. Our findings
raise the possibility that PCM1 may play a role in survival-associated
pathways in GBM cells. It is noteworthy that under starvation/stressed
extracellular conditions, hedgehog signaling through mouse astrocyte
primary cilia promoted the survival of astrocytes, whereas disrupting the
formation of astrocyte cilia increased apoptosis under the same conditions
[56]. Recent studies also suggest that stress/DNA damage response
pathways engage mechanisms that lead to ciliogenesis [57]. For example,
it was demonstrated that PCM1 subcellular localization is significantly
altered in response to genotoxic stresses in U2OS cells [25]. That study
reported that PCM1 granules undergo rapid displacement from
centriolar satellites and centrosomes following exposure to heat shock,
UV light, or transcriptional inhibitors such as DRB and Actinomycin
D, which resulted in the formation of new cilia [25]. Thus, the reduced
capacity of PCM1-depleted and KIF3A-depleted GBM cells to form
cilia may render these cells less capable of responding to
DNA-damaging reagents such as TMZ. Considering that KIF3A/
cilia-depleted cells did not show a change in PCM1 expression pattern
compared with control cells and PCM1 depletion did not have an
additive effect on TMZ sensitivity with KIF3A depletion, the increased
TMZ sensitivity of PCM1-depleted GBM cells may be caused by their
reduced ability to form or sustain ciliogenesis; however, themechanisms
underlying this process still need to be elucidated.
In conclusion, the results of our studies highlight functional
relationships between PCM1, ciliogenesis, and cell proliferation and
sensitivity to TMZ in GBM. Future studies will need to examine the
downstream molecular targets of PCM1 and whether disrupting
PCM1 and other centrosomal proteins/associated pathways could
further sensitize GBM cells to TMZ and/or other conventional
therapies such as irradiation.
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